As a pediatric emergency doctor, I know there are times when a child’s pain is so severe that they need stronger medications like opioids to help them.
The U.S. Food and Drug Administration’s accelerated approval program is meant to give patients early access to promising drugs. But how often do these drugs actually improve or extend patients’ lives?
With its reduced injection frequency, insulin icodec (Awiqli) has the potential to provide better adherence and greater treatment satisfaction in some patients.
